These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36826628)

  • 1. Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota.
    Latteri S; Sofia M; Puleo S; Di Vincenzo A; Cinti S; Castorina S
    Langenbecks Arch Surg; 2023 Feb; 408(1):101. PubMed ID: 36826628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
    Debédat J; Amouyal C; Aron-Wisnewsky J; Clément K
    Semin Immunopathol; 2019 Jul; 41(4):461-475. PubMed ID: 31025085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery.
    Martínez-Montoro JI; Kuchay MS; Balaguer-Román A; Martínez-Sánchez MA; Frutos MD; Fernández-García JC; Ramos-Molina B
    Obes Rev; 2022 Feb; 23(2):e13367. PubMed ID: 34729904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review.
    Talavera-Urquijo E; Beisani M; Balibrea JM; Alverdy JC
    Surg Obes Relat Dis; 2020 Sep; 16(9):1361-1369. PubMed ID: 32336663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis.
    Cerreto M; Santopaolo F; Gasbarrini A; Pompili M; Ponziani FR
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study.
    Van Olden CC; Van de Laar AW; Meijnikman AS; Aydin O; Van Olst N; Hoozemans JB; De Brauw LM; Bruin SC; Acherman YIZ; Verheij J; Pyykkö JE; Hagedoorn M; Sanderman R; Bosma NC; Tremaroli V; Lundqvist A; Olofsson LE; Herrema H; Lappa D; Hjorth S; Nielsen J; Schwartz T; Groen AK; Nieuwdorp M; Bäckhed F; Gerdes VEA
    J Intern Med; 2021 Mar; 289(3):340-354. PubMed ID: 32640105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric surgery and the liver-Mechanisms, benefits, and risks.
    Lefere S; Onghena L; Vanlander A; van Nieuwenhove Y; Devisscher L; Geerts A
    Obes Rev; 2021 Sep; 22(9):e13294. PubMed ID: 34002452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE INTESTINAL MICROBIOME IN PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW.
    Gentile JKA; Oliveira KD; Pereira JG; Tanaka DY; Guidini GN; Cadona MZ; Siriani-Ribeiro DW; Perondini MT
    Arq Bras Cir Dig; 2022; 35():e1707. PubMed ID: 36542005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
    Thondam SK; Cuthbertson DJ; Wilding JPH
    Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
    Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF
    Nutrition; 2022; 103-104():111836. PubMed ID: 36202025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Gut Microbiome in Pediatric Obesity and Bariatric Surgery.
    Akagbosu CO; Nadler EP; Levy S; Hourigan SK
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients.
    Pérez-Rubio Á; Soluyanova P; Moro E; Quintás G; Rienda I; Periañez MD; Painel A; Vizuete J; Pérez-Rojas J; Castell JV; Trullenque-Juan R; Pareja E; Jover R
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity.
    Anhê FF; Zlitni S; Zhang SY; Choi BS; Chen CY; Foley KP; Barra NG; Surette MG; Biertho L; Richard D; Tchernof A; Lam TKT; Marette A; Schertzer J
    Gut; 2023 Mar; 72(3):460-471. PubMed ID: 36008102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD.
    Gart E; Souto Lima E; Schuren F; de Ruiter CGF; Attema J; Verschuren L; Keijer J; Salic K; Morrison MC; Kleemann R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study.
    Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA
    Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease.
    Dong TS; Katzka W; Yang JC; Chang C; Arias-Jayo N; Lagishetty V; Balioukova A; Chen Y; Dutson E; Li Z; Mayer EA; Pisegna JR; Sanmiguel C; Jacobs JP
    Gut Microbes; 2023; 15(1):2167170. PubMed ID: 36732495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity.
    Wang G; Wang Y; Bai J; Li G; Liu Y; Deng S; Zhou R; Tao K; Xia Z
    Front Endocrinol (Lausanne); 2022; 13():1024769. PubMed ID: 36686492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.